DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)

116.56 1.73 (1.51%)

REAL-TIME: Last trade at

Extended Hours: $117.25 $0.69 (0.59%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PCYC $116.56 1.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $116.00
Previous Close $114.83
Daily Range $114.09 - $117.00
52-Week Range $82.51 - $154.89
Market Cap $8.8B
P/E Ratio 98.15
Dividend (Yield) $0.00 (0.0%)
Volume 457,008
Average Daily Volume 849,797
Current FY EPS $0.26

Sector

Healthcare

Industry

Drugs

PHARMACYCLICS, INC. (PCYC) Description

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

News & Commentary

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg

Bristol-Myers Squibb's Opdivo and Merck's Keytruda are sought after drugs for combination cancer treatments.

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leuk

Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leukemia

Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog

Interesting PCYC Put And Call Options For January 2017

15 Surprising Cancer Statistics

Cancer is among the scariest diagnoses. These 15 statistics speak to both the seriousness of the disease and the progress that's being made fighting it.

See More PCYC News...

PCYC's Top Competitors

PCYC $116.56 (1.51%)
Current stock: PCYC
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB